Literature DB >> 21756448

Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy.

Cengiz Basoglu1, Ozgur Oner, Alpay Ates, Ayhan Algul, Yasin Bez, Mesut Cetin, Hasan Herken, Mehmet Emin Erdal, Kerim M Munir.   

Abstract

OBJECTIVE: The molecular genetic of personality disorders has been investigated in several studies; however, the association of antisocial behaviours with synaptosomal-associated protein 25 (SNAP25) gene polymorphisms has not. This association is of interest as SNAP25 gene polymorphism has been associated with attention-deficit hyperactivity disorder and personality.
METHODS: We compared the distribution of DdeI and MnII polymorphisms in 91 young male offenders and in 38 sex-matched healthy control subjects. We also investigated the association of SNAP25 gene polymorphisms with severity of psychopathy and with temperament traits: novelty seeking, harm avoidance, and reward dependence.
RESULTS: The MnII T/T and DdeI T/T genotypes were more frequently present in male subjects with antisocial personality disorder (APD) than in sex-matched healthy control subjects. The association was stronger when the frequency of both DdeI and MnII T/T were taken into account. In the APD group, the genotype was not significantly associated with the Psychopathy Checklist-Revised scores, measuring the severity of psychopathy. However, the APD subjects with the MnII T/T genotype had higher novelty seeking scores; whereas, subjects with the DdeI T/T genotype had lower reward dependence scores. Again, the association between genotype and novelty seeking was stronger when both DdeI and MnII genotypes were taken into account.
CONCLUSION: DdeI and MnII T/T genotypes may be a risk factor for antisocial behaviours. The association of the SNAP25 DdeI T/T and MnII T/T genotypes with lower reward dependence and higher novelty seeking suggested that SNAP25 genotype might influence other personality disorders, as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756448      PMCID: PMC3166635          DOI: 10.1177/070674371105600605

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  19 in total

1.  Fusion of cells by flipped SNAREs.

Authors:  Chuan Hu; Mahiuddin Ahmed; Thomas J Melia; Thomas H Söllner; Thomas Mayer; James E Rothman
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder.

Authors:  V Kustanovich; B Merriman; J McGough; J T McCracken; S L Smalley; S F Nelson
Journal:  Mol Psychiatry       Date:  2003-03       Impact factor: 15.992

4.  Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder.

Authors:  C L Barr; Y Feng; K Wigg; S Bloom; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

5.  Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder.

Authors:  Jonathan Mill; Sarah Curran; Lindsey Kent; Alison Gould; Louise Huckett; Sandra Richards; Eric Taylor; Philip Asherson
Journal:  Am J Med Genet       Date:  2002-04-08

6.  Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population.

Authors:  K Brophy; Z Hawi; A Kirley; M Fitzgerald; M Gill
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

7.  Genome-wide association scan for five major dimensions of personality.

Authors:  A Terracciano; S Sanna; M Uda; B Deiana; G Usala; F Busonero; A Maschio; M Scally; N Patriciu; W-M Chen; M A Distel; E P Slagboom; D I Boomsma; S Villafuerte; E Sliwerska; M Burmeister; N Amin; A C J W Janssens; C M van Duijn; D Schlessinger; G R Abecasis; P T Costa
Journal:  Mol Psychiatry       Date:  2008-10-28       Impact factor: 15.992

8.  Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD.

Authors:  J Mill; S Richards; J Knight; S Curran; E Taylor; P Asherson
Journal:  Mol Psychiatry       Date:  2004-08       Impact factor: 15.992

9.  Cloning and sequence analysis of the human SNAP25 cDNA.

Authors:  N Zhao; H Hashida; N Takahashi; Y Sakaki
Journal:  Gene       Date:  1994-08-05       Impact factor: 3.688

10.  Temperament, character, and personality disorders: etiologic, diagnostic, treatment issues.

Authors:  D M Svrakic; S Draganic; K Hill; C Bayon; T R Przybeck; C R Cloninger
Journal:  Acta Psychiatr Scand       Date:  2002-09       Impact factor: 6.392

View more
  5 in total

1.  Non-Mendelian etiologic factors in neuropsychiatric illness: pleiotropy, epigenetics, and convergence.

Authors:  Curtis K Deutsch; William J McIlvane
Journal:  Behav Brain Sci       Date:  2012-10       Impact factor: 12.579

Review 2.  Genetic and Neuroimaging Features of Personality Disorders: State of the Art.

Authors:  Guorong Ma; Hongying Fan; Chanchan Shen; Wei Wang
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

Review 3.  Antisocial personality disorder: a current review.

Authors:  Andrea L Glenn; Alexandria K Johnson; Adrian Raine
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Genome-wide association study of antisocial personality disorder.

Authors:  M-R Rautiainen; T Paunio; E Repo-Tiihonen; M Virkkunen; H M Ollila; S Sulkava; O Jolanki; A Palotie; J Tiihonen
Journal:  Transl Psychiatry       Date:  2016-09-06       Impact factor: 6.222

Review 5.  Born this way? A review of neurobiological and environmental evidence for the etiology of psychopathy.

Authors:  Annabelle Frazier; Patricia A Ferreira; Joseph E Gonzales
Journal:  Personal Neurosci       Date:  2019-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.